Insmed, Inc. (INSM) Reports Q3 Loss of $1.39, Sales Fall Y/Y
Tweet
Share
E-mailGet Alerts INSM Hot Sheet
Price: $120.00 -3.21%
Revenue Growth %: +253.0%
Financial Fact:
Research and development: 23.43M
Today's EPS Names:
VIVO, OCCI, ALZN, More
Revenue Growth %: +253.0%
Financial Fact:
Research and development: 23.43M
Today's EPS Names:
VIVO, OCCI, ALZN, More
Join SI Premium – FREE
Insmed, Inc. (NASDAQ: INSM) reported Q3 EPS of ($1.39), versus ($0.03) reported last year. Revenue for the quarter came in at $400 thousand, versus $1.8 million reported last year.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Insmed Expands Community Impact During Fifth Annual Global Day of Good
- Lennar Corp. (LEN) Misses Q3 EPS by 10c
- Kroger (KR) Tops Q2 EPS by 3c, Misses on Revenue; Offers FY27 EPS Guidance
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
